Modifications to medication plans might be required depending on blood sugar readings and individual responses to treatment
Advances in Therapy, 39 (6), 24522467
This is often the fastest way to overturn a denial when the clinical documentation is strong
Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure, Type 2 diabetes or obstructive sleep apnea
Wegovy is FDA-approved for chronic weight management in individuals who are obese (patients with a BMI of 30 or greater) or overweight (BMI 27 or more) with at least one weight-related health condition
Importantly, for many patients, heartburn and other gastrointestinal symptoms diminish over time as physiological adaptation occurs, though a subset of patients may experience persistent symptoms requiring intervention or medication discontinuation